Rxcurve
HCPCS J1030 · per 40 MG

Methylprednisolone 40 mg inj

This code is not in the latest file (4Q26). It was last listed in 1Q24.

Payment limit per 40 MG, by effective quarter, 1Q21 to 1Q24. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J1030

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
1Q24 $6.419 −$0.783 40 MG Methylprednisolone 40 mg inj v1, posted December 19, 2024
4Q23 $7.202 −$0.411 40 MG Methylprednisolone 40 mg inj v1, posted October 10, 2024
3Q23 $7.613 −$0.471 40 MG Methylprednisolone 40 mg inj v1, posted June 5, 2024
2Q23 $8.084 +$0.029 40 MG Methylprednisolone 40 mg inj v1, posted February 23, 2024
1Q23 $8.055 +$0.603 40 MG Methylprednisolone 40 mg inj v1, posted December 6, 2023
4Q22 $7.452 +$0.526 40 MG Methylprednisolone 40 mg inj v1, posted June 22, 2023
3Q22 $6.926 +$1.011 40 MG Methylprednisolone 40 mg inj v1, posted June 9, 2023
2Q22 $5.915 +$0.217 40 MG Methylprednisolone 40 mg inj v1, posted December 14, 2022
1Q22 $5.698 +$0.073 40 MG Methylprednisolone 40 mg inj v1, posted June 8, 2022
4Q21 $5.625 +$0.074 40 MG Methylprednisolone 40 mg inj v1, posted June 2, 2022
3Q21 $5.551 −$0.184 40 MG Methylprednisolone 40 mg inj v1, posted June 2, 2022
2Q21 $5.735 −$0.069 40 MG Methylprednisolone 40 mg inj v1, posted March 1, 2022
1Q21 $5.804 – 40 MG Methylprednisolone 40 mg inj v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files